We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
A randomized, placebo-controlled phase 2 study of paclitaxel in combination with reparixin compared to paclitaxel alone as front-line therapy for metastatic triple-negative breast cancer (fRida).
- Authors
Goldstein, Lori J.; Mansutti, Mauro; Levy, Christelle; Chang, Jenny C.; Henry, Stephanie; Fernandez-Perez, Isaura; Prausovà, Jana; Staroslawska, Elzbieta; Viale, Giuseppe; Butler, Beth; McCanna, Susan; Ruffini, Pier Adelchi; Wicha, Max S.; Schott, Anne F.; for the fRida Trial Investigators; Alvarez, Ricardo H.; Abu-Khalaf, Maysa; Ibrahim, Nuhad; Daniel, Brooke; Meshad, Michael
- Publication
Breast Cancer Research & Treatment, 2021, Vol 190, Issue 2, p265
- ISSN
0167-6806
- Publication type
Article
- DOI
10.1007/s10549-021-06367-5